Open AccessCreutzfeldt‐Jakob disease with neuroleptic malignant syndrome
Author(s) -
Čiauškaitė Julija,
Puleikytė Ieva,
Jesmanas Simonas,
Jurkevičienė Giedrė,
Vaitkus Antanas,
Rastenytė Daiva
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4699
Subject(s) - neuroleptic malignant syndrome , medicine , quetiapine , disease , complication , antipsychotic , pediatrics , psychiatry , schizophrenia (object oriented programming) , surgery , pathology
Creutzfeldt‐Jakob disease (CJD) is a rare rapidly progressive fatal neurodegenerative disease. Neuroleptic malignant syndrome (NMS) is a complication of antipsychotic medications which may be used to treat neuropsychiatric symptoms of CJD. We present a case of a 51‐year‐ old woman with CJD who developed NMS after being prescribed quetiapine.